| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f11390a0601d6520c1d8695c6a4f6744 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2496-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-106664 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate |
2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b67800d87769a2579d5ef675c9796cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab719af766eae5f2a71d10d130c62774 |
| publicationDate |
2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2015201260-A1 |
| titleOfInvention |
Composition for use as an abnormal coagulation control plasma in in vitro assays |
| abstract |
Abstract Composition for use as an abnormal coagulation control plasma in in vitro assays. The present invention relates to the field of the clinical analysis of blood, and in particular to a composition comprising human plasma, buffered isotonic solution and ferulic acid to be used as the abnormal coagulation control in haemostasis, coagulation and fibrinolysis assays. The present invention also relates to the use of ferulic acid in the preparation of abnormal control plasma in haemostasis assays. |
| priorityDate |
2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |